Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/1996
05/23/1996WO1996015269A2 Mesoscale polynucleotide amplification devices
05/23/1996WO1996015268A1 Diagnostic method and kit for determining kell blood group genotype
05/23/1996WO1996015267A1 Rapid detection and identification of nucleic acid variants and pathogens
05/23/1996WO1996015265A1 METHODS FOR MODULATING TRANSCRIPTION FROM THE AMYLOID β-PROTEIN PRECURSOR (APP) PROMOTER
05/23/1996WO1996015262A2 Method for the detection of ras oncogenes, in particular the 12-ras oncogene
05/23/1996WO1996015261A2 Nucleotide sequences hybridizing specifically with a genomic nucleic sequence of campylobacter
05/23/1996WO1996015252A2 Vector and methods for introducing at least two genes into a plant
05/23/1996WO1996015251A1 Dna sequence and its use
05/23/1996WO1996015250A1 STRAINS OF BAKERY YEAST CAPABLE OF EXPRESSING AND EXPORTING TO THE CELLULAR EXTERIOR THE ENZYME a-(1-4)-AMILASE OF ASPERGILLUS ORYZAE: PRODUCTION PROCESS AND APPLICATION
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015248A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
05/23/1996WO1996015247A1 Purified papillomavirus proteins
05/23/1996WO1996015246A1 Dna which regulates gene expression in coryne-form bacteria
05/23/1996WO1996015245A1 A process of inhibiting non-neoplastic pathological cell proliferation
05/23/1996WO1996015244A2 Sensory and motor neuron derived factor (smdf)
05/23/1996WO1996015243A1 Transcription factor e2f-4
05/23/1996WO1996015242A2 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor
05/23/1996WO1996015241A2 A polynucleotide tuberculosis vaccine
05/23/1996WO1996015240A2 Ribozyme analogs
05/23/1996WO1996015239A2 Isoflavone reductase promoter
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015237A2 Delivery system
05/23/1996WO1996015229A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/23/1996WO1996015222A1 HUMAN MutT2
05/23/1996WO1996015220A1 Process for functional expression of the para cation channel
05/23/1996WO1996015152A1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof
05/23/1996WO1996015149A2 Methods and compositions for screening for presynaptic calcium channel blockers
05/23/1996WO1996015147A1 Human stanniocalcin-alpha
05/23/1996WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer
05/23/1996WO1996015145A1 BETA3 INTEGRIN SUBUNIT SPECIFIC POLYPEPTIDES, cDNAs WHICH ENCODE THESE POLYPEPTIDES AND METHODS OF PRODUCING THESE POLYPEPTIDES
05/23/1996WO1996015144A2 Chromosome 21 gene marker, compositions and methods using same
05/23/1996WO1996015140A1 Process for purification of factor viii
05/23/1996WO1996014934A1 Mesoscale sample preparation device and systems for determination and processing of analytes
05/23/1996WO1996014933A1 Mesoscale devices for analysis of motile cells
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014875A1 Novel nucleic acid molecules comprising the prostate specific antigen (psa) promoter and uses thereof
05/23/1996WO1996014873A2 COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY
05/23/1996WO1996014863A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996WO1996014861A1 Glial derived neurotrophic factor as a neuroprotective agent
05/23/1996WO1996014860A1 Process for identifying para cation channel modulators
05/23/1996WO1996014836A1 Method and apparatus for gene therapy
05/23/1996WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
05/23/1996WO1996014746A1 A method of inducing resistance to tumor growth
05/23/1996WO1996014734A1 Organism with inhibited expression of s-adenosylhomocysteine hydrolase gene
05/23/1996WO1996012020A3 Hemoglobin receptors from neisseriae
05/23/1996WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
05/23/1996WO1996009389A3 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein
05/23/1996WO1996009066A3 Method of treatment of human immunodeficiency virus (hiv) infection
05/23/1996CA2206110A1 Methods and compositions for screening for presynaptic calcium channel blockers
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2205029A1 Delivery system
05/23/1996CA2205017A1 Method for the detection of ras oncogenes, in particular the k-ras oncogene
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents
05/23/1996CA2204871A1 Methods for modulating transcription from the amyloid .beta.-protein precursor (app) promoter
05/23/1996CA2204870A1 Ribozyme analogs
05/23/1996CA2204863A1 Method for identifying protective antigens for eliciting neutralizing antibodies
05/23/1996CA2204849A1 Process for identifying para cation channel modulators
05/23/1996CA2204770A1 Process for functional expression of the para cation channel
05/23/1996CA2204744A1 Dna sequence and its use
05/23/1996CA2204669A1 Novel nucleic acid molecules comprising the prostate specific antigen (psa) promoter and uses thereof
05/23/1996CA2204665A1 Beta3 integrin subunit specific polypeptides, cdnas which encode these polypeptides and methods of producing these polypeptides
05/23/1996CA2204597A1 Suppression of proteolytic activity by dysfunctional protease formation
05/23/1996CA2204379A1 Sensory and motor neuron derived factor (smdf)
05/23/1996CA2204131A1 Isoflavone reductase promoter
05/23/1996CA2203934A1 Targeted t lymphocytes
05/23/1996CA2203654A1 Human stanniocalcin-alpha
05/23/1996CA2203525A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712935A2 Method for controlling the gene expression in lactic acid bacteria
05/22/1996EP0712934A2 Proteins with fibrinolytic and anticoagulant activity
05/22/1996EP0712933A2 Isolated DNA encoding the FseI restriction endonuclease and related methods for producing the same
05/22/1996EP0712932A2 A human flavin-containing monooxygenase
05/22/1996EP0712931A2 Interferon-gamma production inducing polypeptide, monoclonal antibody, and agent for interferon-gamma susceptive disease
05/22/1996EP0712930A2 A transgenic nonhuman animal model for diabetes
05/22/1996EP0712929A2 A transgenic nonhuman animal deficient in T-cells
05/22/1996EP0712928A2 T cell antigen receptor
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712861A2 Acylated insulin analogs
05/22/1996EP0712444A1 In vivo nucleic acid hybridization method
05/22/1996EP0712442A1 Vaccine compositions
05/22/1996EP0712414A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
05/22/1996EP0712413A1 Antimicrobial proteins
05/22/1996EP0712314A1 Monogenous preparations of cytotoxic conjugates
05/22/1996EP0712277A1 Jak kinases and regulation of cytokine signal transduction
05/22/1996EP0712273A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
05/22/1996EP0712272A1 Transgenic plants containing multiple disease resistance genes
05/22/1996EP0677056B1 Oligonucleotide alkylphosphonates and alkylphosphonothioates
05/22/1996EP0565548B1 Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/22/1996CN1123038A Antisense oligonucleotides which combat aberrant splicing and methods of using the same
05/22/1996CN1122835A Method for detecting virus associated with hemorrhagic fever with renal syndrome
05/22/1996CN1122833A Fermentation method for producing D-ribose novel strain, and method for prepn. of D-ribose using said strain
05/21/1996USRE35248 Method for producing the Hinc II restriction endonuclease and methylase
05/21/1996US5519164 Expression of a multigene RNA having self-splicing activity
05/21/1996US5519127 Nucleic acid probes for the detection of Pneumocystis carinii
05/21/1996US5519125 Plant adenylosuccinate synthetase and DNA coding therefor
05/21/1996US5519120 Urokinase-type plasminogen activator receptor antibodies